Stem cells and kidney regeneration
- PMID: 24434243
- DOI: 10.1016/j.jfma.2013.12.001
Stem cells and kidney regeneration
Abstract
Kidney disease is an escalating burden all over the world. In addition to preventing kidney injury, regenerating damaged renal tissue is as important as to retard the progression of chronic kidney disease to end stage renal disease. Although the kidney is a delicate organ and has only limited regenerative capacity compared to the other organs, an increasing understanding of renal development and renal reprogramming has kindled the prospects of regenerative options for kidney disease. Here, we will review the advances in the kidney regeneration including the manipulation of renal tubular cells, fibroblasts, endothelial cells, and macrophages in renal disease. Several types of stem cells, such as bone marrow-derived cells, adipocyte-derived mesenchymal stem cells, embryonic stem cells, and induced pluripotent stem cells are also applied for renal regeneration. Endogenous or lineage reprogrammed renal progenitor cells represent an attractive possibility for differentiation into multiple renal cell types. Angiogenesis can ameliorate hypoxia and renal fibrosis. Based on these studies and knowledge, we hope to innovate more reliable pharmacological or biotechnical methods for kidney regeneration medicine.
Keywords: bioengineered kidney; endothelial progenitor cell; kidney regeneration; renal progenitor cell; stem cell.
Copyright © 2014. Published by Elsevier B.V.
Similar articles
-
Stem cells in kidney diseases.J Stem Cells. 2012;7(4):245-59. J Stem Cells. 2012. PMID: 24196799 Review.
-
Adult stem cells in renal injury and repair.Nephrology (Carlton). 2005 Jun;10(3):276-82. doi: 10.1111/j.1440-1797.2005.00373.x. Nephrology (Carlton). 2005. PMID: 15958042 Review.
-
Kidney regeneration and stem cells.Anat Rec (Hoboken). 2014 Jan;297(1):129-36. doi: 10.1002/ar.22801. Epub 2013 Dec 2. Anat Rec (Hoboken). 2014. PMID: 24293404 Review.
-
Stem cell therapy for the kidney?Am J Ther. 2009 May-Jun;16(3):247-56. doi: 10.1097/MJT.0b013e3181800591. Am J Ther. 2009. PMID: 19092639 Review.
-
Regenerative medicine in kidney disease.Kidney Int. 2016 Aug;90(2):289-299. doi: 10.1016/j.kint.2016.03.030. Epub 2016 May 24. Kidney Int. 2016. PMID: 27234568 Review.
Cited by
-
Bioartificial Kidneys.Curr Stem Cell Rep. 2017 Jun;3(2):68-76. doi: 10.1007/s40778-017-0079-3. Epub 2017 Apr 12. Curr Stem Cell Rep. 2017. PMID: 33005562 Free PMC article.
-
Suppressive effects of induced pluripotent stem cell-conditioned medium on in vitro hypertrophic scarring fibroblast activation.Mol Med Rep. 2015 Apr;11(4):2471-6. doi: 10.3892/mmr.2014.3115. Epub 2014 Dec 18. Mol Med Rep. 2015. PMID: 25524174 Free PMC article.
-
Downregulated Expression of CLEC9A as Novel Biomarkers for Lung Adenocarcinoma.Front Oncol. 2021 Sep 20;11:682814. doi: 10.3389/fonc.2021.682814. eCollection 2021. Front Oncol. 2021. PMID: 34616670 Free PMC article.
-
Understanding Mesangial Pathobiology in AL-Amyloidosis and Monoclonal Ig Light Chain Deposition Disease.Kidney Int Rep. 2020 Jul 21;5(11):1870-1893. doi: 10.1016/j.ekir.2020.07.013. eCollection 2020 Nov. Kidney Int Rep. 2020. PMID: 33163710 Free PMC article. Review.
-
Continuous AMD3100 Treatment Worsens Renal Fibrosis through Regulation of Bone Marrow Derived Pro-Angiogenic Cells Homing and T-Cell-Related Inflammation.PLoS One. 2016 Feb 22;11(2):e0149926. doi: 10.1371/journal.pone.0149926. eCollection 2016. PLoS One. 2016. PMID: 26900858 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources